BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28325190)

  • 1. Neuroendocrine Tumors of the Stomach.
    Corey B; Chen H
    Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastric neuroendocrine tumors].
    Alekberzade AV; Krylov NN; Lipnitskiy EM; Shakhbazov RO; Azari F
    Khirurgiia (Mosk); 2019; (12):111-120. PubMed ID: 31825351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
    Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
    J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion.
    Tatsuta T; Yoshimura T; Hasui K; Takasugi K; Sawaya M; Hanabata N; Shimoyama T; Kijima H; Fukuda S
    Intern Med; 2013; 52(15):1697-701. PubMed ID: 23903502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
    Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
    Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological relevance of gastric neuroendocrine tumors.
    Klöppel G; Clemens A
    Yale J Biol Med; 1996; 69(1):69-74. PubMed ID: 9041691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
    Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Types of Gastric Cancer Caused by the Same Underlying Condition.
    Rustgi N; Shroff SG; Katona BW
    Gastroenterology; 2018 Apr; 154(5):1246-1248. PubMed ID: 29410354
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastric neuroendocrine tumours.
    Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
    Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
    Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
    Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection].
    Scherübl H; Faiss S; Jahn HU; Liehr RM; Schwertner C; Steinberg J; Stölzel U; Weinke T; Zimmer T; Klöppel G
    Dtsch Med Wochenschr; 2009 Jul; 134(30):1529-35. PubMed ID: 19603370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
    Chen WC; Warner RR; Ward SC; Harpaz N; Divino CM; Itzkowitz SH; Kim MK
    Dig Dis Sci; 2015 Apr; 60(4):996-1003. PubMed ID: 25399327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Other Gastric and Duodenal Neuroendocrine Tumors.
    Laird AM; Libutti SK
    Surg Oncol Clin N Am; 2020 Apr; 29(2):253-266. PubMed ID: 32151359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An atypical type I gastric neuroendocrine tumor.
    Gheorghe AV; Rimbas M; Ginghina O; Spanu A; Voiosu TA
    Rom J Intern Med; 2017 Dec; 55(4):253-256. PubMed ID: 28710883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.